title: Fenofibrate and statin therapy, compared with placebo and statin, slows the development of retinopathy in type 2 diabetes patients of 10 years duration: the ACCORD study.
authors.affiliation: Oxford Centre for Diabetes and Endocrinology, Churchill Hospital, Oxford, OX3 7LJ, UK. david.matthews@ocdemox.ac.uk
authors.forename: David R
authors.initials: DR
authors.lastname: Matthews